Roger Trinh Talent Solutions is proud to partner with a dynamic Houston-based Biopharma company at the forefront of Cell and Gene Therapy (CGT) development. We seek an innovative Chief Medical Officer (CMO) with a proven track record in CGT-ONCO to lead cutting-edge initiatives. This is an opportunity to contribute remotely while providing strategic guidance to a team committed to collective success over individual gain. Join an environment of capital efficiency and platform prioritization, where our client is on the fast track for FDA approval and commercialization.

Key Responsibilities:

• Lead drug development efforts for Oncology solid tumor indication.
• Expertise in Immune checkpoint drugs.
• Proficiency in Cell Therapy, with a particular focus on autologous CAR-T.
• Phase 3 trial experience, demonstrating co-authorship in publications supporting such trials.
• Oversee the BLA (Biologics License Application) submission process for oncology drugs.
• Facilitate engagement and presentation at FDA advisory boards (experience in this area is a strong plus).

Requirements:

• Medical degree (MD or equivalent) with specialized training in Oncology.
• Proven experience developing drugs for Oncology solid tumor indications, specifically in immune checkpoint and cell therapy (autologous CAR-T).
• Strong background in Phase 3/pivotal trials with a demonstrated history of co-authored publications.
• Prior success in leading BLA submissions for oncology drugs.
• Experience presenting and engaging with FDA advisory boards (a significant advantage).

Why Join This Great Organization:

• Work with a visionary team shaping the future of CGT in Oncology.
• Enjoy the flexibility of a remote work arrangement.
• Benefit from the mentorship of top specialists and decisive leaders on our advisory board.
• Contribute to a culture prioritizing collective goals and groundbreaking innovations.
• If you're passionate about revolutionizing CGT in Oncology and making a lasting impact, we invite you to apply.

Please feel free to Roger Trinh at roger@rogertrinh.com about this opportunity.